The Human Immunoglobulin Market is expected to increase by USD 9696 million billion. As per the research report 2024-2028 published by Technavio, the market is expected to grow at a CAGR of 10.11% during the forecast period. The industry is segmented by Application (Autoimmune disorders, Hematology diseases, Inflammatory diseases, Infectious diseases, and Others), End-user (Hospitals, Clinics, and Ambulatory surgical center (ASC)), and Geography (North America, Europe, Asia, and Rest of World (ROW)).
The Human Immunoglobulin (HIG) market represents a significant business opportunity due to the increasing prevalence of immunodeficiency disorders and infectious diseases. HIG is a protein-based therapy used for primary and secondary immunodeficiencies, as well as for the prevention and treatment of various infectious diseases. Key market drivers include the rising incidence of immunodeficiency disorders, technological advancements, and growing demand for home therapy. Major players in the market include Grifols, CSL Behring, and Octapharma.
Know what factors are driving the market growth - Access free sample report
The North America hold the largest regional market size in the current year. The Human Immunoglobulin (HIg) market represents a significant business opportunity due to the increasing prevalence of immunodeficiency disorders and infectious diseases. HIg is a protein-based therapeutic used for preventing and treating various conditions, including primary and secondary immunodeficiencies, hemolytic diseases, and infectious diseases. Market growth is driven by factors such as rising healthcare expenditures, technological advancements, and growing awareness of these conditions. Key players in the market include Grifols, CSL Behring, and Octapharma, among others.
Know which companies are participating in the market- Download the report
The global biotechnology industry encompasses businesses involved in the research and development (R&D) or production of various biotechnology offerings, including biologics, biosimilars, bio-betters, and biotech reagents. According to Technavio, the global healthcare market size is determined by the consolidated revenue generated by manufacturers and providers of medical equipment, supplies, pharmaceuticals, biotechnology, and life sciences tools and services. Key growth drivers in the healthcare sector include the increasing aging population, with the number of individuals over 60 years old in the US projected to reach approximately 25% by 2050, and Europe expected to achieve a similar demographic ratio by 2030.
The Human Immunoglobulin Market is experiencing significant growth, fueled by the Increase in plasma donation. Businesses are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
The Human Immunoglobulin (HIG) market is witnessing significant growth due to the increasing prevalence of immunological disorders in the geriatric population. Immunoglobulins, also known as antibodies, are proteins produced by the immune system to fight against antigens. HIGs, specifically Intravenous Immunoglobulin (IVIG) and Subcutaneous Immunoglobulin (SCIG), are used to treat various conditions such as Guillain-Barre Syndrome, Primary Immunodeficiency (PI), and auto-immune disorders like Myasthenia gravis. IVIG and SCIG possess immunomodulatory and anti-inflammatory properties, making them effective treatment options for immunodeficiencies and autoimmune diseases. The global HIG market is driven by the rising prevalence of these disorders, particularly in the geriatric population, and the increasing demand for patient convenience through at-home treatments. The market is segmented based on therapeutic applications, including neurology, hematology, and immunization programs. Key players in the market include Grifols, CSL Behring, and Shire. The market is also driven by healthcare initiatives and infrastructure development in emerging economies. However, the high cost of HIGs and the presence of alternatives like Vitamin K Antagonist remain challenges for market growth. In conclusion, the Human Immunoglobulin market is expected to continue its growth trajectory due to the increasing burden of immunological disorders, particularly in the geriatric population, and the development of new therapeutic applications and at-home treatments.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted
One user only.
Quick & easy download option
Unlimited user access (Within your organization).
Complimentary Customization Included
*For Enterprise license, go to checkout page
Get the report (PDF) sent to your email within minutes.
